Vaccination is a medical product that gives active immunity against a specific disease. Dog vaccines protect dogs from infectious diseases that can cause illness or death. They improve the health and lifespan of dogs and help prevent the spread of diseases between dogs and humans affordably. Vaccines contain bacteria, viruses, and other organisms that protect against harmful viruses like canine distemper and hepatitis. Vaccines are essential for keeping pets healthy.
Drivers: The dog vaccine market has seen significant growth recently, mainly due to the rising number of pet adoptions worldwide. As more people adopt dogs, the demand for preventative healthcare, including vaccinations, is increasing. Pet owners are becoming more aware of the importance of vaccines for their dogs' health, contributing to this market expansion. Furthermore, the increasing prevalence of infectious diseases like parvovirus, distemper, and rabies highlights the need for vaccinations as an essential part of responsible pet ownership. Veterinary professionals and animal health organizations promote regular vaccinations, supporting market growth.
Challenges: Strict regulatory frameworks, the high expense of vaccine production, and the requirement for cold chain logistics to guarantee vaccination efficacy are some of the obstacles to market expansion. Furthermore, expansion may be hampered by pet owners' sporadic vaccine hesitation brought on by false information or worries about negative reactions.
Market Trends: Technological advancement is a major trend in the dog vaccines market. Companies are using new technology for vaccine development. For example, in September 2022, Merck Animal Health launched Nobivac Intra-Trac Oral BbPi, the first oral vaccine that offers mucosal protection and is easy to give. This vaccine is for healthy dogs aged 7 weeks or older, targeting the canine parainfluenza virus and Bordetella bronchiseptica. It utilizes the innovative Immuno-Mist-R technology by Intervet, a Merck & Co subsidiary, to enhance mucosal surface area contact.
Major companies in the dog vaccines market aim to introduce new rabies vaccines, including a three-dose vaccine, to stay competitive. These innovative vaccines focus on enhancing effectiveness, accessibility, and ease of use for rabies immunization. For example, in April 2022, Cadila Pharmaceuticals from India launched ThRabis, a new three-dose rabies vaccine made with recombinant nanoparticle technology. This vaccine uses virus-like particle technology and produces antibodies to neutralize the virus and prevent it from attaching to cells, offering protection against rabies.
Global Dog Vaccines Market Key Players:
Boehringer Ingelheim International GmbH, Zoetis Services LLC, Merck & Co., Inc, Elanco, Hester Biosciences Limited, Virbac, Bioveta a.s, Brilliant Bio Pharma, Heska Corporation, and Zendal Group are just a few of the major market players that are thoroughly examined in this market study along with revenue analysis, market segments, and competitive landscape data.
Global Dog Vaccines Market Segmentation:
By Vaccine Type: Based on the Vaccine Type, Global Dog Vaccines Market is segmented as; Modified/ Attenuated Live, Inactivated, Other Vaccines.
By Disease Type: Based on the Disease Type, Global Dog Vaccines Market is segmented as; Canine Distemper, Canine Infectious Respiratory Disease Complex, Canine Parvovirosis/ Parvovirus Disease, Canine Leptospirosis, Canine Lyme Disease, Infectious Canine Hepatitis, Canine Rabies, Other Diseases.
By Route of Administration: Based on the Route of Administration, Global Dog Vaccines Market is segmented as; Injectables, Intranasal, Oral.
By Duration of Immunity: Based on the Duration of Immunity, Global Dog Vaccines Market is segmented as; 1 Year, 3 Year, Others.
By Component: Based on the Component, Global Dog Vaccines Market is segmented as; Combined Vaccines, Mono Vaccines.
By Distribution Channel: Based on the Distribution Channel, Global Dog Vaccines Market is segmented as; Retail, E-Commerce, Hospital/Clinic Pharmacies.
By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.